舌咽神经痛中舌咽迷走神经复合体切断术联合或不联合微血管减压术后的无痛生存
该研究回顾性分析18例舌咽神经痛患者,17例行舌咽迷走神经复合体切断术联合或不联合微血管减压术。末次随访(平均9.33年)时15例(88%)无痛,中位无痛生存7.5年±10.6个月,初始无痛率94%,短期并发症常见但长期多数缓解。
要点
- 舌咽迷走神经复合体切断术联合或不联合微血管减压术可使94%患者初始无痛。
- 末次随访平均9.33年时88%患者无痛,中位无痛生存7.5年±10.6个月。
- 短期常见吞咽困难、声音嘶哑、同侧听力下降等,长期部分持续但多数愿意再次手术。
核心结论
- 舌咽迷走神经复合体切断术联合或不联合舌咽神经微血管减压术是安全有效的手术疗法,初始无痛率94%,长期无痛缓解优异(平均7.5年)。
研究设计与样本
- 回顾性病历回顾联合生活质量电话调查,纳入18例舌咽神经痛患者,其中17例行舌咽迷走神经复合体切断术,根据有无压迫血管联合或不联合微血管减压术。
主要发现
- 17例手术患者中,11例舌咽迷走神经复合体受压于小脑后下动脉,1例受压于椎动脉,5例无压迫。
- 1例(6%)术后即刻无疼痛缓解;15例(88%)在末次随访(平均9.33年,范围5.16-13年)时无痛。
- 1例(6%)在3个月时舌咽部疼痛复发;中位无痛生存期为7.5年±10.6个月。
- 17例手术患者中13例(77%)在2周时有短期并发症:吞咽困难4例、声音嘶哑4例、同侧听力下降4例、同侧味觉丧失2例、头晕2例;9例在末次随访时有持续副作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Glossopharyngeal neuralgia (GN) is a rare pain condition in which patients experience paroxysmal, lancinating throat pain. Multiple surgical approaches have been used to treat this condition, including microvascular decompression (MVD), and sectioning of cranial nerve (CN) IX and the upper rootlets of CN X, or a combination of the two. The aim of this study was to examine the long-term quality of life and pain-free survival after MVD and sectioning of the CN X/IX complex. METHODS: A combined retrospective chart review and a quality-of-life telephone survey were performed to collect demographic and long-term outcome data. Quality of life was assessed by means of a questionnaire based on a combination of the Barrow Neurological Institute pain intensity scoring criteria and the Brief Pain Inventory-Facial. Kaplan-Meier analysis was performed to determine pain-free survival. RESULTS: Of 18 patients with GN, 17 underwent sectioning of the CN IX/X complex alone or sectioning and MVD depending on the presence of a compressing vessel. Eleven of 17 patients had compression of CN IX/X by the posterior inferior cerebellar artery, 1 had compression by a vertebral artery, and 5 had no compression. One patient (6%) experienced no immediate pain relief. Fifteen (88%) of 17 patients were pain free at the last follow-up (mean 9.33 years, range 5.16-13 years). One patient (6%) experienced throat pain relapse at 3 months. The median pain-free survival was 7.5 years ± 10.6 months. Nine of 18 patients were contacted by telephone. Of the 17 patients who underwent sectioning of the CN IX/X complex, 13 (77%) patients had short-term complaints: dysphagia (n = 4), hoarseness (n = 4), ipsilateral hearing loss (n = 4), ipsilateral taste loss (n = 2), and dizziness (n = 2) at 2 weeks. Nine patients had persistent side effects at latest follow-up. Eight of 9 telephone respondents reported that they would have the surgery over again. CONCLUSIONS: Sectioning of the CN IX/X complex with or without MVD of the glossopharyngeal nerve is a safe and effective surgical therapy for GN with initial pain freedom in 94% of patients and an excellent long-term pain relief (mean 7.5 years).
引用
- Teton ZE, Holste KG, Hardaway FA, et al. Pain-free survival after vagoglossopharyngeal complex sectioning with or without microvascular decompression in glossopharyngeal neuralgia. J Neurosurg. 2019. PMID: 30641844. doi:10.3171/2018.8.JNS18239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。